WEBVTT

00:03.461 --> 00:06.464
- CAR-T cells are a relatively new treatment

00:06.464 --> 00:09.175
that's FDA approved for cancers.

00:09.175 --> 00:12.887
So this is a treatment where
normal immune cells are modified

00:12.887 --> 00:16.599
so that they can identify and kill cancer cells.

00:17.642 --> 00:21.730
- Amongst the many, many types of cells
that are part of the immune system,

00:21.771 --> 00:23.231
one type are called T cells.

00:23.231 --> 00:27.610
One of the things that T cells do
is to literally recognize

00:27.610 --> 00:31.281
when one of our own cells
is infected by something

00:31.281 --> 00:32.699
and destroy that cell.

00:33.867 --> 00:37.996
- Our cancer cells aren't always
that much different from our normal cells.

00:38.163 --> 00:40.999
Our immune system is just not recognizing

00:40.999 --> 00:44.377
these cancer cells as foreign
enough to attack them.

00:44.586 --> 00:46.796
- So we can take T cells out of the body,

00:46.796 --> 00:52.052
and we can engineer them to recognize the specific molecules on a particular cancer

00:52.677 --> 00:56.473
and once a T cell recognizes
something, it can destroy it.

00:57.140 --> 01:02.604
- FDA approval for these cells are
for diseases really of the blood system.

01:02.645 --> 01:04.773
So hematologic neoplasms.

01:04.773 --> 01:07.817
- Many of them are of B cells which are
a different part of the immune system.

01:07.817 --> 01:11.279
But when those cells become
cancerous, which can happen,

01:11.279 --> 01:13.573
these CAR Ts are very effective for those

01:13.615 --> 01:15.742
and many of these patients
have actually been cured.

01:16.659 --> 01:19.162
- Because of the nature of the illnesses,

01:19.162 --> 01:21.206
or the similarities in illnesses

01:22.290 --> 01:25.502
CAR T are being investigated
in autoimmune diseases

01:25.543 --> 01:28.546
for certain diseases like lupus,

01:28.671 --> 01:32.175
scleroderma, even multiple sclerosis,

01:32.175 --> 01:36.304
and we have active trials
for all of those diseases at Yale.

01:40.558 --> 01:43.144
- T cells and B cells are part of
the adaptive immune system.

01:43.144 --> 01:45.522
The B-cell produces novel antibodies

01:45.522 --> 01:48.316
each time it receives new
signals from its T cell.

01:48.316 --> 01:52.904
Without the B cell, you'd be unable
to adapt to new invaders, new viruses.

01:53.029 --> 01:56.741
But what happens with lupus is the
immune system learns to cause

01:56.741 --> 02:00.995
inflammation to self proteins and tissues,
and this in turn causes organ damage,

02:01.079 --> 02:04.791
loss of function, and in some cases
can be a life threatening illness.

02:06.334 --> 02:10.630
We need to be in a position where
we can have a precision diagnosis

02:10.630 --> 02:14.425
and accurate or precision
therapies that are effective

02:14.467 --> 02:18.096
for the variety of organs
that can be involved in lupus.

02:19.180 --> 02:22.058
- The idea with the autoimmune diseases

02:22.058 --> 02:26.187
is that the cells that we're targeting
are actually quite similar

02:26.229 --> 02:31.025
to the cells that we are targeting
with our CAR T for cancers.

02:32.026 --> 02:34.070
- When we use the word autoimmune,

02:34.070 --> 02:35.989
it's the immune system has learned

02:35.989 --> 02:38.992
to produce inflammation to self tissue.

02:39.617 --> 02:44.998
But once the immune cell is educated,
for lack of a better word, against self,

02:44.998 --> 02:48.251
the inflammation is hard to turn off
or can occur sporadically,

02:48.251 --> 02:50.545
and it's difficult to remove that memory,

02:50.545 --> 02:55.300
and the idea in CAR T is to try to remove
the memory around that autoimmunity.

02:56.009 --> 02:59.762
- The CAR T cells are
targeted against these cells,

02:59.762 --> 03:04.434
and they don't really care
if the cells are normal or malignant.

03:04.767 --> 03:09.022
- So once those cells reach zero,
the bone marrow produces new B cells.

03:09.272 --> 03:12.650
Those B cells tend, at least
in the initial studies,

03:12.650 --> 03:15.653
tend to be what we call naive B cells.

03:15.653 --> 03:18.656
They seem to have lost
a hallmark of autoimmunity.

03:19.616 --> 03:22.869
- One of the major appeals to CAR T cells,

03:23.244 --> 03:25.914
as opposed to some other forms of immunotherapy,

03:25.914 --> 03:28.750
be it in malignancy or autoimmune disease,

03:28.750 --> 03:31.669
is that they're quite powerful.

03:31.669 --> 03:34.047
In many cases, the effect is lasting.

03:34.047 --> 03:37.508
We don't usually give
CAR T cells more than once.

03:38.593 --> 03:41.804
- I think this is going to be extremely
impactful for patients

03:41.804 --> 03:44.098
where they're having life threatening disease,

03:44.098 --> 03:45.433
and where the 3 or 4 medicines

03:45.433 --> 03:48.019
that are currently approved
for lupus aren't working for them.

03:48.937 --> 03:51.689
- And for most patients,
once they have the CAR T cells,

03:51.689 --> 03:53.691
there's no other therapy that's prescribed.

03:53.691 --> 03:56.861
So there's good biological reasons to think that

03:56.945 --> 03:59.906
the CAR T cells could be
curing some of these patients.
